Intracellular Interaction of Interleukin (IL)-32α with Protein Kinase Cϵ (PKCϵ) and STAT3 Protein Augments IL-6 Production in THP-1 Promonocytic Cells-Reference-Cited by-同舟云学术

Intracellular Interaction of Interleukin (IL)-32α with Protein Kinase Cϵ (PKCϵ) and STAT3 Protein Augments IL-6 Production in THP-1 Promonocytic Cells

Published:2012-10 Issue:42 Volume:287 Page:35556-35564
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kang Jeong-Woo,Park Yun Sun,Lee Dong Hun,Kim Jung-hee,Kim Man Sub,Bak Yesol,Hong Jintae,Yoon Do-Young

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease;Calabrese;Am. J. Respir Crit. Care Med.,2008

2. Tumor necrosis factor α-induced interleukin-32 is positively regulated via the Syk/protein kinase Cδ/JNK pathway in rheumatoid synovial fibroblasts;Mun;Arthritis Rheum.,2009

3. Epithelial overexpression of interleukin-32α in inflammatory bowel disease;Shioya;Clin. Exp. Immunol.,2007

4. Involvement of IL-32 in activation-induced cell death in T cells;Goda;Int. Immunol.,2006

5. Molecular characterization of IL-32 in human endothelial cells;Kobayashi;Cytokine,2009

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting STAT3 signaling pathway in the treatment of Alzheimer’s disease with compounds from natural products;International Immunopharmacology;2024-11

2. IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling;International Immunopharmacology;2024-11

3. The binding of PKCε and MEG2 to STAT3 regulates IL‐6‐mediated microglial hyperalgesia during inflammatory pain;The FASEB Journal;2024-04-24

4. IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV;The Journal of Infectious Diseases;2023-12-19

5. Impact of interleukin-32α on T helper cell-related cytokines, transcription factors, and proliferation in patients with type 2 diabetes mellitus;Immunopharmacology and Immunotoxicology;2022-10-27